ADA and severe combined immunodeficiency: However, TREC screening will not identify infants with SCID in which a molecular defect lies downstream of T-cell receptor rearrangement, including variants in ZAP70, MHC class II (major histocompatibility complex class II), and ADA (delayed-onset disease) (35–39).